Since the discovery that hepcidin is expressed in the adipose tissue of obese subjects, attention has been increasingly focused on alterations in iron homeostasis that are associated with adiposity. We examined the production of hepcidin, the expression of hepcidin-related genes and the iron content of the adipose tissue in obesity using Swiss mice fed a high-fat diet (HFD). The mice were maintained on a control diet or HFD for 12 or 24 wk, and body weight, adiposity and glucose homeostasis were evaluated. The expression of several genes (hepcidin, TfR1, TfR2, DMT1, FT-heavy, ferroportin, IRP-1, IRP-2 and HIF-1) and the protein expression of hepcidin and IL-6 were quantified. The iron level was assessed using a Prussian blue reaction in paraffin-embedded tissue. After 24 wk on the HFD, we observed increases in the levels of hepcidin in the serum and the visceral adipose tissue. The IL-6 levels also increased in the visceral adipose tissue. Adipocytes isolated from the visceral adipose tissues of lean and obese mice expressed hepcidin at comparable levels; however, isolated macrophages from the stromal vascular fraction expressed higher hepcidin levels. Adipose tissues from obese mice displayed increased tfR2 expression and the presence of iron. Our results indicate that IL-6 and iron may affect the signaling pathways governing hepcidin expression. Thus, the mice fed HFD for 24 wk represent a suitable model for the study of obesity-linked hepcidin alterations. In addition, hepcidin may play local roles in controlling iron availability and interfering with inflammation in adipose tissue.
A relationship between adiposity and alterations in iron homeostasis was first described more than 40 y ago (1) . However, until recently, this topic has been poorly understood; research in this field became popular only after hepcidin was found to be expressed in the adipose tissue of obese subjects (2) . Hepcidin, which was first described in 2001 (3) , is a 25-amino-acid-long, cysteine-rich peptide with weak antimicrobial properties. Hepcidin is regulated by a number of factors, such as liver iron levels, inflammation, hypoxia and anemia. Hepcidin reduces the level of circulating iron by controlling its efflux from cells such as enterocytes, macrophages and hepatocytes via ferroportin internalization and degradation (4) .
During chronic inflammation, which is hypothesized to exist at low levels in obese subjects, hepcidin expression may result in hypoferremia due to decreased duodenal iron absorption and increased iron sequestration by macrophages; this process results in anemia of inflammation (4) . Although iron is required for oxygen transport, it may be toxic because it reacts with oxygen and catalyzes the production of reactive oxygen species. Therefore, organisms have evolved many proteins that can transport and store iron in a non-toxic form (5) .
During inflammation, hepcidin expression is apparently induced by interleukin (IL)-6, which is known to be involved in the development of obesity and insulin resistance (4, 6) . In obesity, the expanded adipose tissue mass (which contains a significant number of infiltrating macrophages) seems to produce one-third of all detected plasma IL-6 (7) . In fact, IL-6 expression correlates with hepcidin expression in human adipose tissue, and IL-6 treatment induces hepcidin expression in adipose tissue explants (2) . A stromal vascular fraction (SVF) displayed higher hepcidin expression than adipocytes isolated from obese adipose tissue, suggesting that macrophages may contribute to hepcidin production (2) .
High-fat diet (HFD)-induced obesity in mice is a useful model that can be used to study adipose tissue inflammation. We aimed to determine whether a HFD could induce changes in hepcidin levels in adipose tissue and whether infiltrated macrophages contribute to this phenomenon. We also analyzed the expression of several genes that regulate or are regulated by hepcidin, and we measured iron levels in the adipose tissue in experimentally induced obesity.
Materials and Methods
Animals. Male, 8-wk-old Swiss strain mice (33.460.4 g) that were free of specific pathogens were obtained from CEMIB (State University of Campinas, Campinas, SP, Brazil). The experiments were performed in accordance with the principles outlined by the Brazilian College for Animal Experimentation (COBEA) and received approval from the Ethics Committee of São Francisco University, Bragança Paulista, SP, Brazil (Protocol 001.02.10). The animals were maintained on a 12 : 12 h artificial light-dark cycle and housed individually.
Diet-induced obesity and metabolic status. After random selection, the mice were introduced to a control (15% energy from fat) or high-fat diet (HFD; 60% energy from fat) ( Table 1) . Body weights and food intake were assessed weekly. The mice were evaluated after 12 or 24 wk on a HFD. One week before the feeding protocols ended, glucose and insulin tolerance tests were performed. For the glucose tolerance test, mice were fasted for 6 h, and blood samples were collected from the tails (time 0). A solution of 20% glucose (2.0 g/ kg body weight) was injected into the peritoneal cavity (i.p.). To determine the serum glucose concentrations, blood samples were collected from the tail at 30, 60, 90 and 120 min. Glucose levels were measured using the glucose oxidase method, and the obtained values were plotted as a curve. Insulin (1.5 U/kg) was administered by an i.p. injection, and blood samples were collected for serum glucose determination at 0, 5, 10 and 15 min. The rate constant for glucose disappearance during an insulin tolerance test (kITT) was calculated using the formula 0.693/t1/2. The glucose t1/2 was calculated from the slope of the least-square analysis of the plasma glucose concentrations during the linear decay phase. The basal glucose level was also determined at the end of the feeding protocol before the animals were euthanized.
Blood and tissue collection. After 6 h of fasting, the mice were anesthetized with xylazine/ketamine (1 : 1 v/v of xylazine 2%-ketamine 10%), and blood samples were collected by cardiac puncture. Blood/EDTA was used to analyze the hematological parameters, and serum samples were obtained from the collected blood lacking an anticoagulant solution for EIA quantification of hepcidin. Serum was also employed for iron measurements using a colorimetric test (BioClin, Belo Horizonte, MG, Brazil). Epididymal and subcutaneous adipose tissues were carefully dissected and weighed. Fragments of adipose tissue were homogenized in solubilizing buffer at 4˚C (1% Triton X-100, 100 mm Tris-HCl (pH 7.4), 100 mm sodium pyrophosphate, 100 mm sodium fluoride, 10 mm EDTA, 10 mm sodium orthovanadate, 2.0 mm PMSF and 0.1 mg aprotinin/mL). Any insoluble material was removed by centrifugation for 20 min at 9,000 3g at 4˚C. The protein concentrations of the supernatants were determined by the Biuret method. The supernatants were employed in EIA measurements of hepcidin and IL-6. The epididymal adipose tissue and liver fragments were immediately collected and stored at 280˚C in the RNAlater solution (Qiagen, Valencia, CA). Fragments of epididymal adipose tissue were also collected and fixed in paraformaldehyde.
Macrophage and adipocyte isolation from adipose tissue. Epididymal adipose tissue was digested in a collagenase solution (100 mg/mL in Krebs-Henseleit buffer) for 45 min at 37˚C with constant shaking (100 cycles/min). The cells were filtered through nylon mesh (180 mm) and washed three times with Krebs-Henseleit buffer. The stromal vascular fraction (SVF) was collected after the cell suspension was centrifuged, and the adipocytes were collected after flotation. Macrophages (CD11b1 cells) were obtained from the SVF via magnetic-activated cell sorting (MACS, Miltenyi Biotec, Germany). The isolated adipocytes and macrophages were stored at 280˚C in RNAlater solution (Qiagen). In these experiments, primarily in the control diet (non-obese) group, the epididymal adipose tissues from different animals were pooled due the low amount of sample obtained.
Measurement of IL-6 and hepcidin proteins. IL-6 and hepcidin were quantified in serum and adipose tissue samples using commercial EIA kits (IL-6 from R&D Systems, Minneapolis, MN; hepcidin from USCN Life Science, Wuhan, China).
RNA extraction and quantitative real-time polymerase chain reaction. Total RNA was isolated from isolated cells or tissues using the RNeasy Mini kit (Qiagen). Single-stranded cDNA was synthesized using a High-capacity cDNA archive kit (Applied Biosystems, Foster City, CA) following the manufacturer's protocol. Quantitative polymerase chain reaction (PCR) was performed using a 7300 real-time PCR system (Applied Biosystems), and the threshold cycle numbers were determined using the RQ STUDY software program (Applied Biosystems). The reactions were performed in triplicate, and the threshold cycle numbers were averaged. Each 50 mL reaction was prepared as follows: 25 mL of Platinum SYBR Green Quantitative PCR SuperMix-UDG (Invitrogen Life Technologies, Alameda, CA), 10 nm each primer ( Table 2) and 100 ng cDNA. The reaction was subjected to a preliminary UDG treatment for 2 min at 50˚C and a denaturation for 2 min at 95˚C; this process was followed by 45 cycles of denaturation at 95˚C for 15 s, annealing for 15 s and primer extension at 72˚C for 15 s. A melting point analysis of the double-stranded amplicons was then performed using 40 cycles of 1˚C decrements (15 s each) beginning at 95˚C. The first derivative of this plot, dF/dT, represents the rate of fluorescence change in the reaction; a significant change in fluorescence accompanies the melting curve of the double-stranded PCR products. A plot of dF/dT vs. temperature was used to display these changes as distinct peaks. The expression levels of the genes listed in Table 2 were examined and normalized to a constitutively expressed gene (GAPDH), and the relative fold induction was calculated according to the formula 2 (2DDCt) (8) .
Immunohistochemistry and Prussian blue reaction in adipose tissue. Hydrated 5.0 mm sections of paraformaldehyde-fixed, paraffin-embedded adipose tissue specimens were probed with anti-rabbit F4/80 (1 : 50; Santa Cruz Biotechnology, Santa Cruz, CA); they were then probed with a biotinylated anti-rabbit secondary antibody and developed with DAB (ImmunoCruz ABC Staining System, Santa Cruz Biotechnology). Hematoxylin was used to reveal the nuclear morphology. Slides were additionally incubated with a 5% potassium ferrocyanide aqueous solution and a 5% hydrochloric acid aqueous solution, providing the Prussian blue reaction. After washing in distillated water, the sections were counterstained with Nuclear Fast Red. Isolated macrophages (CD11b1 cells) were also subjected to Prussian blue reaction.
Statistical analysis. All of the data are expressed as the means6SE. Comparisons among groups of data were performed using unpaired Student's t tests. An associated probability (p value) of less than 5% was considered to be significant.
results

Obesity, metabolic and hematological alterations
Swiss mice that were fed a HFD for 12 wk became obese and contained large amounts of visceral and subcutaneous adipose tissue, concurrent with the establishment of glucose tolerance and insulin resistance ( Table  3 ). An increased length of the HFD-feeding period only worsened these parameters (Table 3 ). In obese mice, leukocyte number was increased in both groups (Table   Table 2 . Primers used in real-time polymerase chain reactions.
Primer
Sense Antisense
. 2 Primer designed from a consensus region to amplify both the HEPC1 and HEPC2 genes. (Table 4 ). Food intake was not different between groups at 24 wk (4.660.4 and 4.360.2 g/d for control and HFD, respec tively).
Hepcidin expression in adipose tissue during the development of obesity
The subcutaneous and visceral adipose tissues and sera from mice that were fed a HFD for 12 wk displayed normal hepcidin protein levels. However, we observed a significant increase of hepcidin protein levels in the visceral (epididymal) adipose tissue and serum from the mice that were maintained on the diet for 24 wk (Fig.   1 ). The expression of hepcidin-1 but not hepcidin-2 was higher in the adipose tissue from the 24-wk group compared with the lean group (Table 5) . Hepcidin-1 expression was higher than hepcidin-2 expression in all of the samples tested (Tables 5 and 7 ). The use of an additional primer that could amplify both genes (named hepcidin) confirmed increased hepcidin expression in the visceral adipose tissue of mice fed a HFD for 24 wk (Table 5 ). In the same group (24 wk on the HFD), the gene and protein levels of IL-6 were significantly increased in the visceral adipose tissue ( Table 5 ; Fig. 2 ). We also analyzed the expression of several genes related to hepcidin expression in whole adipose tissue. We observed an increase in the expression of transferrin receptor-2 (TfR2) and a decrease in the expression of bone morphogenetic protein-6 (BMP6) and iron regulatory protein-2 (IRP2) in adipose tissues from obese mice (24 wk). The expression levels of TfR1, divalent metal transporter (DMT1), ferritin heavy chain (FT-heavy), Ferroportin, IRP-1 and hypoxia inducible factor (HIF-1) were not altered ( Table 5 ). Adipocytes that were isolated from epididymal adipose tissues from lean and obese mice (24 wk) displayed no significant differences with respect to their hepcidin expression levels (Table 6 ). However, macrophages isolated from SVF from epididymal adipose tissue from obese mice displayed increased hepcidin levels ( Table 6 ). In the experiment using isolated cells, only the primer (named hepcidin) designed from a consensus region common to both genes was employed due the low level of sample obtained.
Hepcidin expression in the liver during obesity
Hepcidin-1 gene expression was significantly lower in the liver of obese mice (24 wk). Hepcidin-2 expression was also reduced, but the reduction was not statistically significant (p50.104). These data were consistent with those generated by using hepcidin primer (Table 7) .
Macrophage infiltration into adipose tissue and Prussian blue reaction in adipose tissue
The maintenance of Swiss mice on a HFD for 24 wk resulted in a dramatic increase in the number of macrophages that infiltrated between the adipocytes (Fig.  3) . Sections of the same adipose tissue depot incubated with potassium ferrocyanide in an acidic environment were labeled with small blue dots between the adipocytes ( Fig. 3) , demonstrating the presence of iron or ferritin. The presence of macrophages with intense blue dots was also more evident in cells from the adipose tissue of obese mice (Fig. 3) .
discussion
Obesity is associated with chronic, low-grade, systemic inflammation that is evidenced by increased plasma and adipose tissue levels of several pro-inflammatory mediators. Although hepcidin expression is Significantly different from the control, ** p,0.01 (n53-4). increased in abdominal subcutaneous adipose tissue from obese subjects, this change is not correlated with morbidities such as diabetes and nonalcoholic steatohepatitis (2) . Few studies have evaluated hepcidin expression in adipose tissue, and an experimental model that can reproduce hepcidin alterations in obesity will be useful. Swiss mice that were fed a HFD for 24 wk (but not those fed the same diet for 12 wk) displayed high hepcidin levels in both their serum and visceral adipose tissue. The increased hepcidin expression in the adipose tissue was dependent on more than just increased adiposity or metabolic alterations, such as glucose tolerance and insulin resistance, because these alterations were already present after 12 wk on the HFD. However, hepcidin expression clearly correlated with increased quantities of IL-6 in the visceral adipose tissue; these levels were only observed after 24 wk on a HFD. Pini and coworkers (9) reported that C57BL6 mice fed a HFD for 17 wk displayed higher IL-6 levels in the visceral adipose tissue. The authors further demonstrated that these levels were associated with hyperinsulinemia and normoglycemia and that the mice displayed normal hepcidin gene (Hepcidin-1 and 2) expression in adipose tissue. Although only one hepcidin gene is thought to exist in the human genome, the mouse genome seems to contain two hepcidin genes with similar genomic organization schemes (10) . Both genes are expressed in adult tissues, and their expression levels are increased in the liver following iron overload (10) . Our protein analysis did not discriminate between mouse hepcidin-1 and 2, and the primer used to perform quantitative RT-PCR in isolated cells was designed from a consensus region common to both genes. In the tissue analysis, all of the hepcidin primers were used (hepcidin-1, hepcidin-2 and hepcidin), and the analysis generated similar results to the quantitative RT-PCR analysis. The increased hepcidin protein expression levels in the serum and visceral adipose tissue were only observed after 24 wk of HFD, suggesting that this effect may represent a late event in models of diet-induced obesity. In humans, the hepcidin gene was found to be expressed in both isolated adipocytes and in the SVF (2) . The human THP-1 monocyte cell line and rodent macrophage cell lines also express hepcidin, and this expression increased following a LPS stimulus (2, 11) . Our findings demonstrate for the first time that CD11b1 cells (macrophages) isolated from the SVF of epididymal adipose tissue express more hepcidin during obesity in mice. Notably, a significant macrophage infiltration into adipose tissue is observed during obesity, and these cells exist in an activated status; they can produce and secrete several adipokines that act locally and systemically. No differences in hepcidin expression were observed in isolated adipocytes during obesity. However, because the amount of adipose tissue is increased in obesity, the adipose tissue itself could contribute to the elevated hepcidin serum levels, anemaia and hypoferremia that were observed in our mice. Interestingly, the hepcidin gene expression level in the liver decreased significantly in the obese mice (24 wk). The same experimental group showed increased hepcidin levels in the serum but decreased hepcidin levels in the liver, which is the primary site of hepcidin production. We hypothesized that hepcidin mRNA reduction in liver could be a response to hypoferremia or due an increase of circulating hepcidin protein detected as a homeostatic response. We next analyzed the visceral adipose tissue expression levels of several genes that are potentially related to hepcidin. The stimulatory effect of IL-6 on hepcidin is transcriptional and depends on interactions between STAT3 and a STAT3-binding element in the hepcidin promoter (12) . The hepcidin gene is most likely sensitive to IL-6 and other inflammatory stimuli due to the ancestral antimicrobial properties of the peptide. Iron overload can also induce hepcidin expression, which results in a protective effect whereby hepcidin controls iron availability to the tissues, thus preventing the production of free radicals (13) . However, hepcidin regulation by iron is not fully understood. Transferrin receptor 2 (TfR2) is a candidate mediator of iron-mediated regulation of hepcidin synthesis in the liver (14) . We observed a significant increase in TfR2 expression in the visceral adipose tissue, suggesting that iron may also help to regulate hepcidin expression in adipose tissue during obesity. Moreover, the level of bone morphogenetic protein (BMP)-6 also increases in the liver in response to iron overload (15) . However, our results showed a significant reduction in BMP-6 gene expression in adipose tissue, suggesting that this pathway is not involved in obesity-induced changes in hepcidin. Although the suppression of hepcidin expression may be caused by hypoxia, the gene expression of hypoxia inducible factor (HIF)-1 was not up-regulated in the visceral adipose tissue of our obese mice. The production of several proteins involved in iron homeostasis is controlled through the interaction of iron regulatory proteins (IRPs) and iron responsive elements (IREs). When iron enters cells, the conformation of IPR-1 is altered, and IRP-2 is degraded. Therefore, neither protein can interact with IREs, resulting in the degradation of TfR1 and divalent metal transporter (DMT)-1 and the transcription of ferritin (16) . The gene expression level of IRP-1 was low, but the expression levels of ferritin heavy chain (FT-HEAVY), TfR1 and DMT-1 were unchanged. These results should be interpreted carefully because these genes are regulated post-transcriptionally. But, the gene expression analyses suggested that the cellular level of iron in the adipose tissue may have increased, and the Prussian blue reaction demonstrated the presence of ferric iron in the adipose tissue sections. Iron localization, which was observed only in the visceral adipose tissues of obese mice, correlated with macrophage infiltration and seemed to exist between the adipocytes. The analysis of Prussian blue reaction in isolated macrophages from adipose tissue confirmed the presence of more ferric iron in these cells during obesity. Adipose tissue macrophages display a peculiar phenotype including the presentation of M2 surface markers, but they can produce cytokines and chemokines like M1 cells (17) . M1 macrophages are characterized by increased iron retention, which is generally understood to represent a bacteriostatic mechanism (18) . The iron retention in these cells also contributes to their increased ability to produce pro-inflammatory cytokines. Ferrous iron causes the endosomal accumulation of superoxide anions in caveosomes, initiating signaling pathways that induce IKK activation. IKK activation leads to NF-kB activation and the induction of M1 genes, such as TNF-a and IL-1b, without interfering with M2 anti-inflammatory gene expression (19) . However, iron retention also contributes to a reduction of the oxidative stress in the microenvironment. Recent studies have reported that the reduction of iron levels in experimentally induced obesity using deferoxamine ameliorates adipocyte hypertrophy by reducing oxidative stress, inflammatory cytokine levels and macrophage infiltration, thus attenuating the deleterious consequences of obesity (20) . Iron can also induce insulin resistance and reduce adiponectin expression in isolated adipocytes (21, 22) . Therefore, further studies should be performed to determine whether hepcidin efficiently controls iron availability in adipose tissues during obesity as a protective mechanism or whether iron retention by adipose tissue macrophage contributes to the M1 phenotypes of these cells and their ability to release pro-inflammatory cytokines. Because adipose tissue contained increased levels of iron and IL-6 and because these components putatively participate in signaling that regulates hepcidin expression, future studies should explore whether increased IL-6 is a cause or consequence of the presence of iron. HFD seems to cause iron deficiency also by a hepcidin-independent mechanism through reduc-tion of duodenal absorption (23) . In mice fed a HFD for 10 wk, duodenal DMT1 and TFR1 mRNA expressions were higher as compared with normal diet animals, suggesting an enterocyte iron deficiency (23) . In the same animals, oxidoreductases Dcyt and hephaestin mRNA expressions were reduced suggesting that the HFD influences directly or indirectly enzymatic activity impairing transport iron across enterocyte membranes (23) . In our animals, duodenal DMT1 and TFRI mRNA were also higher in obese mice in agreement with previous described data (not shown). We cannot rule out the possibility that additional mechanisms, i.e. impaired duodenal absorption, could contribute to the hypoferremia observed in our work.
Thus, when Swiss mice were fed a HFD for 24 wk, hepcidin production was increased by the visceral adipose tissue, which caused a systemic (serum and hepatic) alteration in hepcidin levels. Finally, we hypothesized that hepcidin may play a local role in controlling iron availability in adipose tissue during obesity. Future studies can contribute to the understanding of iron's functions in the physiology of adipocytes and in the interactions between macrophages and adipocytes.
